Skip to main content

Table 2 Treatment characteristics of 84 lesions

From: Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

Variables

Number of patients (%)

Previous treatment (n = 77)

 TACE

41 (53.2)

 TACE + RFA

17 (22.1)

 TACE + PEI

3 (3.9)

 TACE + RFA + PEI

1 (1.3)

 TACE + Resection

6 (7.8)

 TACE + Resection + RFA

6 (7.8)

 TACE + Resection + PEI

1 (1.3)

 TACE + Resection + RFA + PEI

1 (1.3)

 RFA

1 (1.3)

Radiation dose

 35 Gy/10 fractions

7 (8.3)

 40 Gy/10 fractions

27 (32.2)

 50 Gy/10 fractions

50 (59.5)

Radiotherapy plan

 Three-dimensional conformal radiotherapy

80 (95.2)

 Volumetric-modulated arc therapy

4 (4.8)

Respiratory-gated beam delivery

 Yes

79 (94.0)

 No

5 (6.0)

  1. TACE transarterial chemoembolization, RFA radiofrequency ablation, PEI percutaneous ethanol injection